Zobrazeno 1 - 10
of 123
pro vyhledávání: '"E, Engelsman"'
Autor:
D Becquart, J.G.M. Klijn, Luc Duchateau, Jacek Jassem, E. Engelsman, Louk V.A.M. Beex, M.A. Nooij, J. Wildiers, J.C.J.M. de Haes
Publikováno v:
European Journal of Cancer. 39:614-621
The optimal duration of cytostatic treatment for metastatic breast cancer is still a matter of debate. Possible gain in the duration of remission has to be weighed against the side-effects of treatment. Our aim was to define the optimal duration of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f700b8c2020adeec76c19f3f0ac429b5
https://doi.org/10.1016/s0959-8049(02)00869-9
https://doi.org/10.1016/s0959-8049(02)00869-9
Autor:
J. Wildiers, Richard Sylvester, N. Rotmensz, Louk V.A.M. Beex, J.C.M. Klijn, E. Engelsman, M.A. Nooij, Robert D. Rubens
Publikováno v:
European Journal of Cancer and Clinical Oncology. 27:966-970
The “classical” CMF (cyclophosphamide/methotrexate/5-fluorouracil) schedule was compared with a modified 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer, as concern had arisen as to whether the classical s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bb92dfd26692bfb89624e434911e689
https://doi.org/10.1016/0277-5379(91)90259-g
https://doi.org/10.1016/0277-5379(91)90259-g
Autor:
M A, Nooij, J C J M, de Haes, L V A M, Beex, J, Wildiers, J, Klijn, D, Becquart, J, Jassem, E, Engelsman, L, Duchateau
Publikováno v:
European journal of cancer (Oxford, England : 1990). 39(5)
The optimal duration of cytostatic treatment for metastatic breast cancer is still a matter of debate. Possible gain in the duration of remission has to be weighed against the side-effects of treatment. Our aim was to define the optimal duration of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::07c14d06ff0ade71d1c6f363702406b8
https://pubmed.ncbi.nlm.nih.gov/12628840
https://pubmed.ncbi.nlm.nih.gov/12628840
SUMMARY IL-2 production by mitogen-induced peripheral blood mononuclear cells was reported to be reduced in several autoimmune diseases, including Graves'disease (GD). This production defect in hyperthyroid GD was restored to normal by antithyroid dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db58f6ec79fe7412be4e435c403af6ae
https://europepmc.org/articles/PMC1534893/
https://europepmc.org/articles/PMC1534893/
Publikováno v:
Cancer. 67(6)
In 58 breast cancer patients with meningeal carcinomatosis (MC) pretreatment characteristics, clinical course, and response to treatment were evaluated. Forty-four patients were uniformly treated with intraventricular chemotherapy. Fourteen patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e85ad1e726ee98272d50a7bf42b5d3de
https://pubmed.ncbi.nlm.nih.gov/2001559
https://pubmed.ncbi.nlm.nih.gov/2001559
Publikováno v:
International Journal of Gynecological Pathology. 4:75-82
The clinical history of a patient with a placental-site trophoblastic tumor is presented. The diagnostic and therapeutic value of dilatation and curettage, the human chorionic gonadotropin titer, hysteroscopy, laparoscopy, chemotherapy, and hysterect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88ed268303d3b1cc2b030d045e866c1e
https://doi.org/10.1097/00004347-198501000-00006
https://doi.org/10.1097/00004347-198501000-00006
Autor:
G. J. F. P. Hanewald, J.F.A.K. van Benthem, F. S. A. M. Van Dam, E. Engelsman, A. C. G. Linssen
Publikováno v:
Pharmaceutisch weekblad. 1:501-515
In dit onderzoek werd nagegaan hoe patienten met mammacarcinoom een behandeling met cytostatica verdragen. Daartoe werden drie groepen in het onderzoek betrokken, namelijk een groep patienten met metastasen die palliatieve chemotherapie kreeg, een tw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44a7af31c6a59bc9c1e197750ce03388
https://doi.org/10.1007/bf02293260
https://doi.org/10.1007/bf02293260
Publikováno v:
European Journal of Cancer and Clinical Oncology. 21:291-299
In this study 263 patients with advanced measurable breast cancer were randomized to receive cyclophosphamide, methotrexate and 5-fluorouracil (CMF) or CMF + tamoxifen (T). Each cycle of CMF (C, 100 mg/m2 p.o. days 1-14, M 40 mg/m2 i.v. days 1 and 8,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18a82ee355562ba6d7e562f97e842431
https://doi.org/10.1016/0277-5379(85)90128-2
https://doi.org/10.1016/0277-5379(85)90128-2
Autor:
E. van der Schueren, P.J. Winter, J. Papadiamantis, Robert D. Rubens, E. Engelsman, S.D. Vassilaros, J. Wildiers, Richard Sylvester, John L. Hayward, H. Bartelink, N. Rotmensz
Publikováno v:
European Journal of Cancer and Clinical Oncology. 25:667-678
Patients with locally advanced carcinoma of the breast were randomized to receive either radiotherapy alone, radiotherapy + endocrine therapy, radiotherapy + chemotherapy or radiotherapy + endocrine therapy + chemotherapy. In 363 evaluable patients,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::473d788762cd08e82cef6db6f2627eba
https://doi.org/10.1016/0277-5379(89)90203-4
https://doi.org/10.1016/0277-5379(89)90203-4
Autor:
Jgm Bonfrèr, E Hamersma-v.d. Linden, E. Engelsman, W Nooyen, Peter F. Bruning, M. de Jong-Bakker
Publikováno v:
Breast Cancer Research and Treatment. 4:289-295
In a phase II clinical trial, 38 postmenopausal women with advanced breast cancer were treated with aminoglutethimide and replacement hydrocortisone. All women had previously received up to 4 modalities of endocrine therapy. Seventeen patients had al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::706a2be4c856d2a37c608fdc831db3e6
https://doi.org/10.1007/bf01806041
https://doi.org/10.1007/bf01806041